Aurore Morello
Aurore Morello holds a PhD in Immunology and bispecific targeted immunotherapy for cancer treatment and transplantation (Immunoconcept Bordeaux France). After her PhD, she performed a post doc at the Memorial Sloan Kettering Cancer center (MSKCC, New York) in the laboratory of Dr Adusumilli (thoracic surgery department). She worked on development of CAR T cell therapy & combination with immune checkpoint blockade or cell intrinsic strategies for the treatment of solid tumors. Since 2016. She joined OSE Immunotherapeutics French biotech company as Scientist & project became head of research, Director of R&D programs for the development of first in class immunotherapeutic approaches in immuno-oncology and immuno-inflammation using antibodies, immunocytokines and mRNA therapeutic approaches to modulate immune system.